海南發展(002163.SZ):三鑫科技與海控中能建、中國建築設計院組成聯合體參與鶯歌唱晚驛站項目投標
格隆匯11月30日丨海南發展(002163.SZ)公佈,公司的控股子公司深圳市三鑫科技發展有限公司(簡稱“三鑫科技”)與中國建築設計研究院有限公司(簡稱“中國建築設計院”)、公司控股股東海南省發展控股有限公司(簡稱“海發控”)的控股子公司海南海控中能建工程有限公司(簡稱“海控中能建”)簽署《聯合體協議書》,組成聯合體參與公司控股股東全資孫公司海南發控旅遊驛站開發有限公司(簡稱“旅遊驛站”)招標的鶯歌唱晚驛站項目(一期)工程總承包(EPC)(簡稱“鶯歌唱晚驛站項目”)的公開投標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.